Document Detail

Anabolic activity of ursolic acid in bone: Stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo.
MedLine Citation:
PMID:  18822379     Owner:  NLM     Status:  MEDLINE    
In the field of osteoporosis, there has been growing interest in anabolic agents that enhance bone mass and improve bone architecture. In this study, we demonstrated that the ubiquitous plant triterpenoid, ursolic acid, enhances differentiation and mineralization of osteoblasts in vitro. We found that ursolic acid induced the expression of osteoblast-specific genes with the activation of mitogen-activated protein kinases, nuclear factor-kappaB, and activator protein-1. Additionally, noggin, an antagonist of bone morphogenetic proteins (BMPs), inhibited ursolic acid-induced osteoblast differentiation. Noggin also inhibited the activation of Smad and the induction of BMP-2 mRNA expression by ursolic acid in the late stage of osteoblast differentiation. Importantly, ursolic acid was shown to have bone-forming activity in vivo in a mouse calvarial bone formation model. A high proportion of positive immunostaining of BMP-2 was found in the nuclear region of woven bone formed by ursolic acid. These results suggested that ursolic acid has the anabolic potential to stimulate osteoblast differentiation and enhance new bone formation.
Su-Ui Lee; Sang-Joon Park; Han Bok Kwak; Jaemin Oh; Yong Ki Min; Seong Hwan Kim
Related Documents :
35719 - Testicular acid phosphatases of the mouse. characterization after chromatographic fract...
18294959 - Tmem74, a lysosome and autophagosome protein, regulates autophagy.
2838559 - The human nasal mucosa in the menopause (a histochemical and electron microscopic study).
8111349 - Cytochemical analysis of the content of chicken thrombocytes vacuoles.
2717219 - Biochemical characteristics of the metacyclic forms of leishmania major and l. mexicana...
2816909 - Time-dependent cleavage of a high-mannose form of ii to p25 in an intracellular compart...
3653169 - Struvite crystal formation by corynebacterium group d2 in human urine and its preventio...
9509179 - Gastric acid secretion and enteric infection in bangladesh.
2689929 - Diversion colitis: a nutritional deficiency syndrome?
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-09-07
Journal Detail:
Title:  Pharmacological research : the official journal of the Italian Pharmacological Society     Volume:  58     ISSN:  1043-6618     ISO Abbreviation:  Pharmacol. Res.     Publication Date:    2008 Nov-Dec
Date Detail:
Created Date:  2008-12-01     Completed Date:  2009-02-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8907422     Medline TA:  Pharmacol Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  290-6     Citation Subset:  IM    
Laboratory of Chemical Genomics, Korea Research Institute of Chemical Technology, P.O. Box 107, Yuseong-gu, Daejeon 305-600, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alkaline Phosphatase / genetics,  metabolism
Anabolic Agents*
Blotting, Western
Bone Development / drug effects*
Calcium / metabolism
Carrier Proteins / pharmacology
Cell Differentiation / drug effects*
Cell Survival / drug effects
Cells, Cultured
Coloring Agents
Genes, Reporter
Osteoblasts / drug effects*
RNA, Messenger / biosynthesis,  genetics
Skull / cytology,  drug effects
Triterpenes / pharmacology*
Reg. No./Substance:
0/Anabolic Agents; 0/Anthraquinones; 0/Carrier Proteins; 0/Coloring Agents; 0/RNA, Messenger; 0/Triterpenes; 148294-77-3/noggin protein; 7440-70-2/Calcium; 77-52-1/ursolic acid; 83-61-4/Alizarin Red S; EC Phosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aromatase is phosphorylated in situ at serine-118.
Next Document:  NR4A2 controls the differentiation of selective dopaminergic nuclei in the zebrafish brain.